Wierda, W. G., Dorritie, K. A., Gauthier, J., Soumerai, J. D., Kenderian, S., Nath, R., Riedell, P. A., Brander, D. M., Ermann, D. A., Shah, N. N., Ou, S., Sengupta, S., Ray, P., Wang, J., Tuazon, S. A., Ananthakrishnan, R., Siddiqi, T. (2025). Propensity score (PS) comparison between lisocabtagene maraleucel (liso-cel) plus ibrutinib combination therapy (combo) and liso-cel monotherapy (mono) cohorts from TRANSCEND CLL.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.7037